Can a common drug protect organs during sepsis?
NCT ID NCT07454421
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether Racecadotril, a drug given through a feeding tube, can help reduce organ injury in people with sepsis. About 44 adults in intensive care will receive either the drug or a placebo, along with standard sepsis treatment. The main goal is to see if organ function improves over 4 days.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Department of Critical Care Medicine of Zhujiang Hospital,Southern Medical University
Guanzhou, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a key hormone be missing in septic shock?
- Sweat sensor could replace blood draws for sepsis monitoring
- Could a simple mineral cut the need for powerful blood-pressure drugs in septic shock?
- Blood filter aims to calm deadly inflammation in septic shock
- Experts unite to define sepsis care standards for Sub-Saharan africa
- Could a 45-Minute talk after sepsis stop PTSD before it starts?